Package 72162-1609-3
Brand: rivastigmine transdermal system
Generic: rivastigminePackage Facts
Identity
Package NDC
72162-1609-3
Digits Only
7216216093
Product NDC
72162-1609
Description
30 h in 1 PATCH (72162-1609-3)
Marketing
Marketing Status
Brand
rivastigmine transdermal system
Generic
rivastigmine
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["TRANSDERMAL"], "spl_id": "99b5f8a0-5111-41c7-841b-cfa7ff27b4f4", "openfda": {"nui": ["N0000175723", "N0000000177"], "unii": ["PKI06M3IW0"], "rxcui": ["725023"], "spl_set_id": ["1ebeb8ec-5348-4bb1-ab3d-834690351094"], "pharm_class_epc": ["Cholinesterase Inhibitor [EPC]"], "pharm_class_moa": ["Cholinesterase Inhibitors [MoA]"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "30 h in 1 PATCH (72162-1609-3)", "package_ndc": "72162-1609-3", "marketing_start_date": "20241224"}], "brand_name": "Rivastigmine Transdermal System", "product_id": "72162-1609_99b5f8a0-5111-41c7-841b-cfa7ff27b4f4", "dosage_form": "PATCH, EXTENDED RELEASE", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "72162-1609", "generic_name": "Rivastigmine", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Rivastigmine Transdermal System", "active_ingredients": [{"name": "RIVASTIGMINE", "strength": "9.5 mg/24h"}], "application_number": "ANDA209063", "marketing_category": "ANDA", "marketing_start_date": "20191219", "listing_expiration_date": "20261231"}